New York, USA – May 31, 2021 – CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now continues to expand its Metal Organic Frameworks (MOFs) materials portfolio with the launch of Zinc-based MOFs (Fe-MOF) to support drug delivery studies for the research communities. These new MOFs can be possibly applied in various fields including drug delivery and gas adsorption and separation.
Metal-organic frameworks (MOFs) are crystalline materials composed of coordination bonds between transition-metal cations and multidentate organic linkers. MOFs can be used for gas separation and storage, catalysis, and sensing applications. More recently, increasing interest has been attracted to apply MOFs for biomedical applications, such as imaging, sensing, and loading therapeutic agents as delivery vehicles. As an drug delivery company providing customized solutions for developing and producing new, biocompatible drug delivery systems, CD Bioparticles offers porous organic materials for global researchers, including the customized Metal Organic Frameworks with various of the material formats and chemical composition to help scientists solve the challenges might meet.
This new series of Zinc-based MOFs include various products such as the CAU-21-ODB (Catalog:CDM-CH277), IRMOF-3(Catalog:CDM-CH272), and MOF-74 (Mg). More release like ZIF-8, ZIF-90, Zn-ZIF-62, IRMOF-8, and IRMOF-9 are also available at CD Bioparticles. For CAU-21-ODB, the white powder, which is stable in air for several weeks and commonly used in gas adsorption and separation, and drug delivery, can be store at room temperature or 4 °C in dry-state. It is recommend to be activated at 100 °C in a vacuum oven for 3 hours before use.
“CD Bioparticles has developed customized metal organic frameworks with various of the material formats and chemical composition to assist you in the research programs. If you have limited MOF options in the market for different applications or restricted surface area, CD Bioparticles will a good choice for you. Working closely with the research community, we will provide you with the most convenient way to obtain MOFs materials.” said Prof. Jeffrey A. Depaul, M.D., the chief scientific officer of R&D department of CD Bioparticles.
“We hope our Zinc-based MOFs will eventually contribute to our clients’ important research,” said Dr. Robin J. Watts, the scientific officer of R&D department of CD Bioparticles. “We are proud to support their drug delivery work, and are more than willing to do whatever we can for their research.”
Please feel free to contact CD Bioparticles to learn more about MOFs in order to find the right one for your studies. For more detailed information on Zinc-based MOFs for drug delivery, please visit CD Bioparticles at https://www.cd-bioparticles.net.
About CD Bioparticles
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.